Skip to main content
Equibles
CLOV logo

CLOV · Clover Health Investments, Corp. · Metrics

Track CLOV — free

Use CLOV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CLOV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.60 -0.13 (-2.75%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$2.44B
Shares
531.16M
Volume · Oct 23 3.32M Avg daily vol (3M) 4.21M

CLOV metrics

81 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.60
Market cap
$2.44B

Price action

20 metrics
Price change (1W)
+2.7%
Price change (30D)
+6.2%
Price change (3M)
+6.5%
Price change (6M)
+89.3%
Price change (YTD)
+95.7%
Price change (1Y)
+43.8%
Trailing year
Price change (5Y)
-38.7%
52-week high
$5.41
52-week low
$1.70
Change from 52-week high
-15.0%
Change from 52-week low
+170.6%
Annualized volatility
64.9%
Annualized volatility (3M)
56.1%
Beta
1.2
RSI (14D)
50.2
Price vs SMA 50
+2.8%
Price vs SMA 200
+31.7%
Avg volume (3M)
4.21M
Relative volume
0.8
Average dollar volume
$18.91M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
531.16M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.0×
reciprocal yield 101.4%
P / book
6.5
reciprocal yield 15.4%
FCF yield
3.0%
TTM · current market cap
Buyback yield
0.0%
P / FCF
32.9
reciprocal yield 3.0%
P / operating cash flow
31.7
reciprocal yield 3.2%
Earnings yield
-0.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.3×
reciprocal yield 372.3%
EV / revenue historical average (5Y)
0.3×
reciprocal yield 372.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
-0.7%
Trailing 12 months
Net margin
-0.7%
Gross profit (TTM)
$334.89M
Operating profit (TTM)
−$18.36M
Net income (TTM)
−$18.36M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
3.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$4.66
Gross profit per diluted share (TTM)
$0.68
Operating profit per diluted share (TTM)
$-0.04
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-0.04
Operating cash flow per diluted share (TTM)
$0.14
Free cash flow per diluted share (TTM)
$0.14
Capital expenditures per diluted share (TTM)
$0.01
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.14
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+55.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.48B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+7.2%
Year over year · more shares
Revenue CAGR (3Y)
+20.6%
Revenue CAGR (5Y)
+23.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-4.9%
Return on assets
-2.5%
Debt / equity
—
Current ratio
1.5
EBITDA (TTM)
−$20.13M
Free cash flow (TTM)
$74.21M
Quick ratio
1.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$198.84M
Total assets
$720.33M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$77.03M
Capital expenditures (TTM)
$2.83M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$72.38M
R&D / revenue
—
Stock compensation / revenue
2.9%

Ownership (13F)

9 metrics
13F filers
229
13F filer change QoQ
+19
Institutional ownership
30.0%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+16.6%
Holder tenure
10.8
Price vs estimated holder cost
+59.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
10.8%

Short interest

3 metrics
Short interest
4.3%
Latest settlement · 6.3 days to cover
Days to cover
6.3d
Short-squeeze score
68 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.17M
Insider-sentiment score
52 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1801170 CUSIP 18914F103 13F (30d) 34 filings 34 filers Visit website Investor relations